Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2004 Jun 01;1423:495-500. doi: 10.1038/sj.bjp.0705792.
Show Gene links
Show Anatomy links
Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist.
Luk T
,
Jin W
,
Zvonok A
,
Lu D
,
Lin XZ
,
Chavkin C
,
Makriyannis A
,
Mackie K
.
???displayArticle.abstract???
1 The relationship of agonist efficacy to the rate of G protein-coupled receptor signaling desensitization is controversial. 2 Expressing inwardly rectifying potassium channels (GIRKs) in Xenopus oocytes, we have devised a signaling assay that clearly identifies CB1 cannabinoid receptor agonists with low intrinsic efficacy. 3 In this assay, the synthetic CB1 agonists, AM411, AM782, AM1902, AM2233 and WIN55,212-2 and the endogenous cannabinoid, 2-arachidonoyl ester, were full agonists. 4 The synthetic CB1 agonist AM356 (methanandamide), the endogenous cannabinoids, anandamide and 2-arachidonoyl ether, and the phytocannabinoid, Delta9THC, were partial agonists. 5 The rate of desensitization of CB1 was independent of agonist efficacy. WIN55,212-2, AM782, AM1902, AM2233, and 2-arachidonoyl glycerol ester all desensitized quickly, with desensitization rates varying from 14% min(-1) to 10% min(-1). AM356, AM411, anandamide, and Delta9THC all desensitized considerably slower, at a rate of 5% min(-1). 6 Despite high potency and efficacy, AM411 desensitized as slowly as anandamide and Delta9THC. 7 CB1 agonist efficacy and rate of desensitization are not necessarily related.
Alvarez,
mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization.
2002, Pubmed
Alvarez,
mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization.
2002,
Pubmed
Breivogel,
Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity.
1998,
Pubmed
Dascal,
The use of Xenopus oocytes for the study of ion channels.
1987,
Pubmed
,
Xenbase
Duttaroy,
The effect of intrinsic efficacy on opioid tolerance.
1995,
Pubmed
Fan,
Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.
1994,
Pubmed
Henry,
Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes.
1995,
Pubmed
,
Xenbase
Hillard,
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.
2000,
Pubmed
Howlett,
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.
2002,
Pubmed
Huestis,
Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.
2001,
Pubmed
Hunt,
Tolerance and disposition of tetrahydrocannabinol in man.
1980,
Pubmed
Jin,
Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization.
1999,
Pubmed
,
Xenbase
Kenakin,
Drug efficacy at G protein-coupled receptors.
2002,
Pubmed
Kouznetsova,
Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture.
2002,
Pubmed
Kovoor,
Agonist-induced desensitization of the mu opioid receptor-coupled potassium channel (GIRK1).
1995,
Pubmed
,
Xenbase
Kovoor,
Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy.
1998,
Pubmed
,
Xenbase
Liman,
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
1992,
Pubmed
,
Xenbase
Luttrell,
The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals.
2002,
Pubmed
Mackie,
Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells.
1993,
Pubmed
Matsuda,
Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
1990,
Pubmed
McAllister,
Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system.
1999,
Pubmed
,
Xenbase
Pertwee,
Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.
1993,
Pubmed
Savinainen,
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes.
2001,
Pubmed
Shen,
Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture.
1999,
Pubmed
Walker,
Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats.
2001,
Pubmed
